×
About 348 results

ALLMedicine™ Ochronosis Center

Research & Reviews  118 results

Study of Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00005909

Feb 13th, 2023 - Alkaptonuria is a rare autosomal recessive disorder in which homogentisic acid accumulates and destroys connective tissue and bone, creating a condition called ochronosis. Symptoms generally begin in the third or fourth decade and progress to inca...

Long-term maintenance required in melasma patients
https://www.mdedge.com/dermatology/article/260463/pigmentation-disorders/long-term-maintenance-required-melasma-patients
Doug Brunk

Jan 4th, 2023 - SAN DIEGO – When Arisa E. Ortiz, MD, meets with patients who seek treatment for melasma, she tells them that while she can make their hyperpigmentation better, no cure-all exists for the condition.

Aortic Stenosis Pathology
https://emedicine.medscape.com/article/2018199-overview

Dec 31st, 2022 - Aortic Stenosis Overview Aortic stenosis can be caused by acquired conditions, be the result of a congenital malformation, or be a result of a combination of acquired and congenital processes. Acquired stenosis of the aortic valve, which affects a...

Aortic Stenosis Pathology
https://emedicine.medscape.com/article/2018199-print

Dec 31st, 2022 - Aortic stenosis can be caused by acquired conditions, be the result of a congenital malformation, or be a result of a combination of acquired and congenital processes. Acquired stenosis of the aortic valve, which affects adults, is most often caus...

Aortic Stenosis Pathology
http://emedicine.medscape.com/article/2018199-overview

Dec 31st, 2022 - Aortic Stenosis Overview Aortic stenosis can be caused by acquired conditions, be the result of a congenital malformation, or be a result of a combination of acquired and congenital processes. Acquired stenosis of the aortic valve, which affects a...

see more →

Clinicaltrials.gov  3 results

Study of Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00005909

Feb 13th, 2023 - Alkaptonuria is a rare autosomal recessive disorder in which homogentisic acid accumulates and destroys connective tissue and bone, creating a condition called ochronosis. Symptoms generally begin in the third or fourth decade and progress to inca...

Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
https://clinicaltrials.gov/ct2/show/NCT05206318

Jan 25th, 2022 - Post-inflammatory hyperpigmentation is a common pigmentary skin disorder that is refractory to treatment and troublesome for darker skin individuals. The current treatment with conventional bleaching cream may result in skin irritation and ochrono...

Long-Term Study of Nitisinone to Treat Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00107783

Aug 26th, 2021 - Alkaptonuria is a rare metabolic disease in which homogentisic acid (HGA), an intermediary metabolite in tyrosine catabolism, accumulates due to deficiency of the enzyme homogentisic acid oxidase. Patients with alkaptonuria exhibit homogentisic ac...

see more →

News  18 results

Long-term maintenance required in melasma patients
https://www.mdedge.com/dermatology/article/260463/pigmentation-disorders/long-term-maintenance-required-melasma-patients
Doug Brunk

Jan 4th, 2023 - SAN DIEGO – When Arisa E. Ortiz, MD, meets with patients who seek treatment for melasma, she tells them that while she can make their hyperpigmentation better, no cure-all exists for the condition.

Hydroquinone, Found in Skin Lightening Agents Worldwide, Linked With Increased Skin Cancer Risk
https://www.medscape.com/viewarticle/979800

Aug 26th, 2022 - People who use skin lightening products that contain hydroquinone may be at an increased risk for skin cancers, an analysis of records from a large research database suggests. Brittany Miles In the study, hydroquinone use was associated with an ap...

Online Information About Hydroquinone: An Assessment of Accuracy and Readability
https://www.mdedge.com/dermatology/article/255413/aesthetic-dermatology/online-information-about-hydroquinone-assessment
Stephanie Ishack, PhD, Shari R. Lipner, MD, PhD

Jun 14th, 2022 - To the Editor: The internet is a popular resource for patients seeking information about dermatologic treatments. Hydroquinone (HQ) cream 4% is approved by the US Food and Drug Administration for skin hyperpigmentation.

Going Beyond Hydroquinone: Alternative Skin Lightening Agents
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc

Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.

Topical options for treating melasma continue to expand
https://www.mdedge.com/dermatology/article/253196/pigmentation-disorders/topical-options-treating-melasma-continue-expand
Doug Brunk

Mar 26th, 2022 - BOSTON – In the opinion of Seemal R. Desai, MD, dermatologists are obligated to tell their patients with melasma that their condition is a chronic disease with no cure.

see more →